Hungary’s government is planning a number of cost-cutting measures in the healthcare sector, focusing largely on improving conditions for generic products and reducing the number of people entitled to benefits, the daily Népszabadság reports.
The scheme comprising six measures would largely focus on creating better terms for generic products, which, in light of the current regulations are actually competing with other pharmaceutical goods when it comes to pricing, opposed to western Europe where generic products containing the same agent cost a fraction of their industry-made counterparts. Experts believe the move could add up HUF 30-40 billion in savings.
The package would raise the state contributions of drugmakers, even though they already paid HUF 55 billion to the treasury, which equals 8.7% of the sector’s aggregate turnover. Népszabadság points out that boosting the levies will likely cut back the firms’ development budgets.
The paper also claims knowledge of a plan to reduce the number of Hungarians eligible to retire due to disability by 100,000 saving the budget HUF 120 billion in the process. The measure would target those that qualify for the lowest disability levels, who are often believed to still be capable of work but choose to retire instead.